Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 16, 2025
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)
GlobeNewswire
·
May 16, 2025
RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing …
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that …
First Steroid Cycle: Best Steroids for Muscle Growth (Before And After Result), Steroids for Beginners - By CrazyBulk USA
GlobeNewswire
·
May 16, 2025
New York City, NY, May 16, 2025 (GLOBE NEWSWIRE) -- Initiating the first steroid cycle as a new bodybuilder may be thrilling yet terrifying. Despite all the information and diverse counsel obtainable over the internet, most new bodybuilders are undecided …
Thyroid Support Under Review: Best Thyroid Support Supplements For Thyroid Health & Healthy Thyroid Hormone Production
GlobeNewswire
·
May 16, 2025
Richmond, Virginia, May 16, 2025 (GLOBE NEWSWIRE) -- The thyroid gland is a little organ in our body but a very fascinating one. It sits at the bottom of every human body‘s neck. The shape of the thyroid line resembles that of a butterfly and its healthy …
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American…
GlobeNewswire
·
May 16, 2025
Haploinsufficient SYNGAP1 mice treated with CMP-SYNGAP-01 demonstrated an increase in SYNGAP1 protein levels; treatment rescued multiple SYNGAP1-dependent behavioral phenotypes CMP-SYNGAP-01 administration led to a significant increase in SYNGAP1 protein …
Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
May 16, 2025
Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability and therapeutic potential of the RNAfix® platform in CNS diseases Preclinical data showcases first demonstration of systemically …
Bruno Male Enhancement Australia Legal Alternatives: 2025 User Discover the Biggest Read Bruno Chemist Warehouse Reviews
GlobeNewswire
·
May 16, 2025
Perth, Western Australia, May 16, 2025 (GLOBE NEWSWIRE) -- Is enlargement and enhancing stamina and performance in bed with the growing age possible? Male health issues such as low stamina, low libido, frequent ejaculation, short performance, low cognitive …
Arialief Under Review: The Truth About Arialief and the Nerve Relief Trick
GlobeNewswire
·
May 16, 2025
AURORA, Colo., May 16, 2025 (GLOBE NEWSWIRE) -- What This Review Will Cover The Underlying Inflammation Behind Neuropathic Pain and How Arialief Targets It The 7-Second Nerve Relief Trick: The actual steps behind using Arialief. Key Ingredient Analysis: …
Merus gibt die Veröffentlichung des Wirkmechanismus von Petosemtamab in der Fachpresse bekannt
GlobeNewswire
·
May 16, 2025
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, May 16, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, „das Unternehmen“, „wir“ oder „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper und Antikörper-Wirkstoff- …
Merus annonce la publication d’un article sur le mécanisme d’action du pétosemtamab
GlobeNewswire
·
May 16, 2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 16 mai 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », « la Société », « nous » ou « notre/nos », une société d’oncologie au stade clinique développant des anticorps …
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
GlobeNewswire
·
May 16, 2025
GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes …